Evidence map›Paper›PMID 41717015›Full record

ArticleiScience2026

Suresh Govatati, Chandra Sekhar Yadavalli, Abhinav Sunkara, Gadiparthi N Rao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Suresh GovatatiDepartment of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Chandra Sekhar YadavalliDepartment of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Abhinav SunkaraDepartment of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Gadiparthi N RaoDepartment of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thromboxane prostanoid (TP) receptors play an important role in platelet activation and hemostasis. Although TP receptors undergo palmitoylation within the platelet proteome, its impact on platelet functions and the underlying mechanisms have not been explored. To this end, we report for the first time that Alox15 (aka 12/15-lipoxygenase or 12/15-LOX) mediates TP receptor palmitoylation and its membrane trafficking, influencing platelet activation and hemostasis in response to 10,10-difluorothromboxane A2 (F

Indexed as

biochemistrybiological sciencesphysiology

Identifiers

PMID41717015
PMCPMC12914311

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.